Peter Ordentlich
Peter Ordentlich publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Hematology, on topics such as Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors and Advanced Breast Cancer Therapies.
- World rank
- #1,629,020 of 1,633,909 ranked researchers
- Rank in United States
- #357,313 of 358,040
- Works
- 17
- Citations
- 5
- Citations per work
- 0.3
What does Peter Ordentlich research?
Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.
- 1Molecular Biology51% of their works
- 2Pulmonary and Respiratory Medicine18% of their works
- 3Hematology13% of their works
- 4Oncology8% of their works
- 5Surgery3% of their works
- 6Immunology3% of their works
Research topics
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Advanced Breast Cancer Therapies
- FOXO transcription factor regulation
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Ubiquitin and proteasome pathways
Which keywords describe Peter Ordentlich's research?
The keywords of their largest research topics: Cancer Therapy, HDAC Inhibitors, Histone Deacetylases, BET Bromodomains, PROTACs, Hematopoietic Stem Cells, Breast Cancer and CDK4/6 Inhibitors.
- Ubiquitin
- cell cycle regulation
- Graft-versus-Host Disease
- Fibrosis
- Acute Myeloid Leukemia
- CDK4/6 Inhibitors
- Hematopoietic Stem Cells
- BET Bromodomains
- HDAC Inhibitors
- Cancer Therapy
- Histone Deacetylases
- PROTACs
- Breast Cancer
- AML
- Bone Marrow Niche
- FoxO Transcription Factors
- Idiopathic Pulmonary Fibrosis
- Proteasome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Cancer Therapy92 topics
- HDAC Inhibitors81 topic
- Histone Deacetylases81 topic
- BET Bromodomains51 topic
- PROTACs51 topic
- Hematopoietic Stem Cells42 topics
- Breast Cancer31 topic
- CDK4/6 Inhibitors31 topic
- AML21 topic
- Acute Myeloid Leukemia21 topic
- Bone Marrow Niche21 topic
- Fibrosis21 topic
- FoxO Transcription Factors21 topic
- Graft-versus-Host Disease21 topic
- Idiopathic Pulmonary Fibrosis21 topic
- cell cycle regulation21 topic
- Proteasome11 topic
- Ubiquitin11 topic
Where does Peter Ordentlich work?
Peter Ordentlich's main affiliation in the publication record is Synta Pharmaceuticals (United States), United States.
How many publications and citations does Peter Ordentlich have?
Science Explorer counts 17 works and 5 citations for Peter Ordentlich, ranking #1,629,020 of 1,633,909 researchers worldwide on the composite score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.